Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study).

Makito MiyakeNobutaka NishimuraTakashi InoueShota SuzukiTomomi FujiiTakuya OwariShunta HoriYasushi NakaiMichihiro ToritsukaHitoshi NakagawaShinji TsukamotoSatoshi AnaiKazumasa TorimotoTatsuo YonedaNobumichi TanakaKiyohide Fujimoto

Published in: Trials (2021)

This clinical trial was prospectively registered with the UMIN Clinical Trials Registry on 1 August 2020. The reference number is UMIN000041273 , and the Ethics Committee of Nara Medical University Approval ID is 2702.

Keyphrases

muscle invasive bladder cancer
clinical trial
open label
phase ii
study protocol

double blind
phase iii
phase ii study
placebo controlled
public health

healthcare
randomized controlled trial
quantum dots
big data

squamous cell carcinoma
living cells
machine learning
fluorescent probe